Editor's Note: Green and red arrows refer to intraday stock price movement.NEW YORK ( TheStreet) -- CHANGE IN RATINGS Bank of America ( BAC) was started with a Neutral rating at UBS. $13.50 price target. Company still faces significant headwinds, UBS said. CardioNet ( BEAT) was upgraded at Citigroup to Hold from Sell on early signs of fundamental improvement, Citigroup said. Maintain $4.45 price target. Blackrock ( BLK) was upgraded at Ticonderoga from Neutral to Buy. $225 price target. Company should continue to grow and will likely buyback stock, Ticonderoga said. Citigroup ( C) was initiated with a Buy rating at UBS. $5.60 price target. Company has a strong global position, UBS said. DigitalGlobe ( DGI) was downgraded at Benchmark Company from Buy to Hold. $30 price target. Company is facing a weaker commercial outlook, Benchmark said. Dick's Sporting Goods ( DKS) was upgraded at Oppenheimer to Outperform from Perform. Sales and earnings trends have improved significantly, Oppenheimer said. $50 price target. FEI Company ( FEIC) was upgraded at Merriman Capital to Buy from Neutral. Research/Industry and Life Sciences segments are driving growth, Merriman said. First Solar ( FSLR) was downgraded at Collins Stewart to Hold from Buy. Company could face a multiple contraction, given further delays with the DoE, Collins Stewart said. Goldman Sachs ( GS) was initiated with a Buy rating at UBS. $200 price target. Company has a strong management team and remains focused on its core strengths, UBS said. JP Morgan Chase ( JPM) was initiated with a Buy rating at UBS. $54 price target. Company is using its capital strength as an advantage, UBS said. KAR Auction ( KAR) was downgraded at Robert Baird to Neutral from Outperform. $21 price target. Valuation call, as the stock is up 39% year-to-date, Baird said. Legg Mason ( LM) was downgraded to Market Perform at Keefe, Bruyette & Woods. $39 price target. Company is facing higher compensation costs, KBW said. Morgan Stanley ( MS) was initiated with a Neutral rating at UBS. $28 price target. Company is still in the midst of a turnaround, UBS said. Mylan ( MYL) was downgraded at Morgan Stanley to Equal-Weight from Overweight. $25 price target. Company is facing pricing pressure overseas, Morgan Stanley said. Norfolk Southern ( NSC) was downgraded at Jefferies to Hold. Valuation call, based on a $78 price target, Jefferies said.
Rowan ( RDC) was upgraded at Duncan-Williams to Strong Buy from Sell. $54 price target. Last quarter should prove to be a low point in earnings, Duncan-Williams said. Transocean ( RIG) was upgraded at Global Hunter to Neutral from Reduce. Stock is pricing in the company's lower earnings potential, Global Hunter said. Scotts Miracle-Gro ( SMG) was downgraded at RBC Capital to Sector Perform from Outperform. $61 price target. Company faces increased sales risk given the weather shift, RBC said. Valueclick ( VCLK) was upgraded at Merriman Capital to Buy. Acquisitions are helping to drive growth, Merriman said. Valueclick was upgraded at Jefferies from Hold to Buy. $20 price target. Core segments could see increased growth potential, Jefferies said. Valueclick was upgraded at Needham from Hold to Buy. $25 price target. Company is seeing improved margins, Needham said. Vertex Pharmaceuticals ( VRTX) was downgraded at Brean Murray from Buy to Hold. Valuation call, based on a $53 price target, Brean Murray said. End of report.